SCHEMBL26450320

SCHEMBL26450320

Clc1ccc2oc3cc4nc(-c5ccncc5)oc4cc3c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ CASP3 P42574 2/20 0.54
▸ SENP7 Q9BQF6 2/20 0.54
▸ SENP6 Q9GZR1 1/20 0.54
▸ PIK3CB P42338 2/20 0.52
▸ PIK3CA P42336 1/20 0.52
▸ KDM4E B2RXH2 9/20 0.51
▸ ALDH1A1 P00352 8/20 0.51
▸ HPGD P15428 8/20 0.51
▸ HSD17B10 Q99714 8/20 0.51
▸ NPC1 O15118 4/20 0.51
▸ RAB9A P51151 4/20 0.51
▸ TSHR P16473 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ NFKB2 Q00653 1/20 0.51
▸ RELA Q04206 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26450244 0.95 SMN1; SMN2 (0.54) SMN1; SMN2CASP3SENP7SENP6PIK3CB
SCHEMBL24550784 0.88 SMN1; SMN2 (0.71) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL1025725 0.84 SMN1; SMN2 (0.73) SMN1; SMN2CASP3SENP7SENP6PIK3CB
SCHEMBL24551507 0.82 SMN1; SMN2 (0.71) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL2244230 0.81 PIK3CG (0.57) SMN1; SMN2CASP3SENP7SENP6PIK3CB
SCHEMBL24551452 0.81 SMN1; SMN2 (0.53) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24550880 0.80 SMN1; SMN2 (0.68) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL26450580 0.80 SMN1; SMN2 (0.46) SMN1; SMN2CASP3SENP7SENP6PIK3CB
SCHEMBL24550588 0.80 SMN1; SMN2 (0.67) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL26450514 0.80 MKNK2 (0.47) SMN1; SMN2CASP3SENP7SENP6PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139051-A1 BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-04 — — US disclosed
US-20230139051-A1 BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139051-A1 BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF TSPO, XDH, TARS2 SMN1; SMN2 2909/4885CASP3 699/4885SENP7 1974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback